<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-id journal-id-type="hwp">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26647312</article-id>
<article-id pub-id-type="pmc">4731023</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddv499</article-id>
<article-id pub-id-type="publisher-id">ddv499</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>De novo</italic> dominant <italic>ASXL3</italic> mutations alter H2A deubiquitination and transcription in Bainbridge–Ropers syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Srivastava</surname>
<given-names>Anshika</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ritesh</surname>
<given-names>K.C.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tsan</surname>
<given-names>Yao-Chang</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liao</surname>
<given-names>Rosy</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Su</surname>
<given-names>Fengyun</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cao</surname>
<given-names>Xuhong</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hannibal</surname>
<given-names>Mark C.</given-names>
</name>
<xref ref-type="aff" rid="af4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Keegan</surname>
<given-names>Catherine E.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chinnaiyan</surname>
<given-names>Arul M.</given-names>
</name>
<xref ref-type="aff" rid="af2">2</xref>
<xref ref-type="aff" rid="af3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martin</surname>
<given-names>Donna M.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bielas</surname>
<given-names>Stephanie L.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="af1"><label>1</label><addr-line>Department of Human Genetics</addr-line>,</aff>
<aff id="af2"><label>2</label><addr-line>Howard Hughes Medical Institute, Department of Pathology</addr-line>,</aff>
<aff id="af3"><label>3</label><addr-line>Departments of Urology, Computational Medicine and Bioinformatics</addr-line>, and</aff>
<aff id="af4"><label>4</label><addr-line>Department of Pediatrics</addr-line>, <institution>University of Michigan Medical School</institution>, <addr-line>Ann Arbor, MI</addr-line>, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>To whom correspondence should be addressed at: Department of Human Genetics, University of Michigan Medical School, 3703 Medical Science II, 1137 Catherine St. SPC 5618, Ann Arbor, MI 48109-5618, USA. Tel: +<phone>1 7346478890</phone>; Fax: +<fax>1 7347633784</fax>; Email: <email>sbielas@umich.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>08</day>
<month>12</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>25</volume>
<issue>3</issue>
<fpage>597</fpage>
<lpage>608</lpage>
<history>
<date date-type="received">
<day>8</day>
<month>9</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>5</day>
<month>11</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>1</day>
<month>12</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2015</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="ddv499.pdf"></self-uri>
<abstract>
<p><italic>De novo</italic> truncating mutations in <italic>Additional sex combs-like 3 (ASXL3)</italic> have been identified in individuals with Bainbridge–Ropers syndrome (BRS), characterized by failure to thrive, global developmental delay, feeding problems, hypotonia, dysmorphic features, profound speech delays and intellectual disability. We identified three novel <italic>de novo</italic> heterozygous truncating variants distributed across <italic>ASXL3</italic>, outside the original cluster of <italic>ASXL3</italic> mutations previously described for BRS. Primary skin fibroblasts established from a BRS patient were used to investigate the functional impact of pathogenic variants. <italic>ASXL3</italic> mRNA transcripts from the mutated allele are prone to nonsense-mediated decay, and expression of ASXL3 is reduced. We found that ASXL3 interacts with BAP1, a hydrolase that removes mono-ubiquitin from histone H2A lysine 119 (H2AK119Ub1) as a component of the Polycomb repressive deubiquitination (PR-DUB) complex. A significant increase in H2AK119Ub1 was observed in <italic>ASXL3</italic> patient fibroblasts, highlighting an important functional role for ASXL3 in PR-DUB mediated deubiquitination. Transcriptomes of <italic>ASXL3</italic> patient and control fibroblasts were compared to investigate the impact of chromatin changes on transcriptional regulation. Out of 564 significantly differentially expressed genes (DEGs) in <italic>ASXL3</italic> patient fibroblasts, 52% were upregulated and 48% downregulated. DEGs were enriched in molecular processes impacting transcriptional regulation, development and proliferation, consistent with the features of BRS. This is the first single gene disorder linked to defects in deubiquitination of H2AK119Ub1 and suggests an important role for dynamic regulation of H2A mono-ubiquitination in transcriptional regulation and the pathophysiology of BRS.</p>
</abstract>
<funding-group>
<award-group id="funding-1">
<funding-source>National Institutes of Health <named-content content-type="funder-id">http://dx.doi.org/10.13039/100000002</named-content></funding-source>
<award-id>R00HD069624</award-id>
<award-id>R01 DC009410</award-id>
</award-group>
<award-group id="funding-2">
<funding-source>Donita B. Sullivan Professorship funds</funding-source>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>